FDA Inspection 1315768 — Jiangsu Hansoh Pharmaceutical Group Co., Ltd
The FDA completed an inspection of Jiangsu Hansoh Pharmaceutical Group Co., Ltd on Apr 24, 2026 in Lianyungang. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Apr 24, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)